AbelZeta Pharma

Enabling Immunity

Through innovative and proprietary T-cell-based therapeutics.

Enabling Immunity

Through innovative and proprietary T-cell-based therapeutics.

AbelZeta Pharma is a global clinical-stage biopharmaceutical company focused on leveraging our R&D capabilities to discover and develop T cell-based therapeutic products to treat cancer and inflammatory & immunological diseases.

Hematological Cancers

Solid Tumors

Inflammatory & Immunological Diseases

Our PlatformS

CAR-T​

Chimeric Antigen Receptor (CAR)-T Cell

TIL

Tumor Infiltrating Lymphocytes (TIL)

EMPOWERING YOUR IMMUNE SYSTEM

A Personalized Fight Against Cancer and Inflammatory & Immunological Diseases

Scroll to Top